F_CSS_Comp Posting.pdf

COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

Title: Acquisition of OrganoPlate Graft to be used for SARS_CoV-2 Project

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95022Q00344 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. The anticipated award date is 7/13/2022.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-06, dated 05/26/2022.

(iv) The associated NAICS code 325414 and the small business size standard is 1250 employees.

(v) Project Requirements:

The requested equipment consists of the following Mimetas brand-name or equal goods:

• OrganoPlate Graft. Catalog number 6401-400-B. Quantity 115.

o Microfluidic 3D cell culture plate, 64 chips per plate.

Total shipping price must be included in each offeror’s quote.

(vi) Delivery/Inspection:

Offerors shall provide on their quote a good faith delivery estimate from receipt of an order. Delivery, inspection, and acceptance will be performed at NCATS located at 9800 Medical Center Drive, Rockville, MD 20852.

(vii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition.

(viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and

Commercial Services, applies to this acquisition.

(a) The award resulting from this solicitation will be made to the responsible offeror whose proposal is most advantageous to the Government, Technical Capability, Past Peformance and other factors considered.

(ix) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Items, with its offer.

(x) The FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition.

The following FAR provisions or clauses are incorporated by reference:

52.204-7, System for Award Management (Oct 2018) 52.204-13, System for Award Management Maintenance (Oct 2018) 52.204-16, Commercial and Entity Code Reporting (Aug 2020) 52.204-18, Commercial and Entity Code Maintenance (Aug 2020) 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services of Equipment (Nov 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015).

52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (2/2020).

52.225-6, Trade Agreements Certificate

(xi) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Items, applies to this acquisition

(xii) HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A - Health Resources Priorities and Allocations System.

(xiii) The offeror must complete and return FAR 52.204-24 with its offer.

(xiv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance;

trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

In addition the Unique Entity Indentifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.”

All responses must be received by July 8, 2022, 9:00 am, Eastern Standard Time and reference number 75N95022Q00344. Responses shall be submitted electronically to Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov. Quotes must be submitted in the English language and in US Dollars.

Fax responses will not be accepted.

(xv) The name of the individual to contact for information regarding the solicitation:

Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov.

Attachments:

1. FAR 52.212-5

2. Copy of FAR 52.204-24, to be completed and submitted by offeror

3. Invoice and payment provisions http://www.sam.gov/ mailto:kevin.alvarez@nih.gov mailto:kevin.alvarez@nih.gov